All lobbying filings
MR. BRIAN KELLY
MR. BRIAN KELLY filed a Q1 amendment for TAKEDA PHARMACEUTICAL COMPANY on April 16, 2025, reporting $10,000 in lobbying income.
Lobbying for TAKEDA PHARMACEUTICAL COMPANY · Pharmaceuticals
Filing · LD-2 quarterly report
Q1 amendment
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 16, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Government bodies contacted
5
Lobbying activity
4
Trade and tariffs
Government tariffs on drug imporatation.
Trade/Tariffs on drug pricing and importation
tax issues related to drugs and pricing